TrialDrug design, development and therapy2016

Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study.

Atsushi Tsuruta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.